Liquid biopsies have already been demonstrated to overcome temporal heterogeneity in EGFR T790 M mutant NSCLC after treatment with EGFR inhibitors [[227], [228], [229]]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.